WebPune-based Serum Institute of India continues to lead the Indian biopharmaceutical industry with a revenue of Rs 25000 crore for the year 2024-22 as against Rs 7201 crore for the year 2024-21 followed by Hyderabad-based Bharat Biotech International with revenue of Rs 8352 crore registering a 480 per cent growth over last year at No 2 position and … WebAbout Serum Institute Life Sciences Pvt. Ltd. Serum Institute Life Sciences Pvt Ltd was established as a company which will concentrate on further development of vaccines and therapies against COVID-19 disease. It also has plans to further develop the vaccines against other infectious diseases.
Serum Institute of India restarts manufacturing Covishield vaccine …
WebSep 17, 2024 · 1 min read . Updated: 17 Sep 2024, 05:42 PM IST Livemint. Biocon on Thursday announced alliance with Serum Institute of India (PTI) Biocon Biologics Limited, a subsidiary of Biocon, on Thursday ... WebSep 17, 2024 · Serum Institute of India CEO Adar Poonawalla will join the board of Biocon Biologics. Biocon Biologics and SILS also intend to create antibodies to treat various … most comfortable sneakers for men 2022
Strategic Alliance with Serum Institute to Impact Global …
WebSep 17, 2024 · The deal with Serum Institute Life Sciences values Biocon Biologics at about $4.9 billion and will solely focus on COVID-19 vaccines in the initial years, the companies said. The 15% stake in the Biocon unit is valued at more than $730 million, Biocon's Executive Chairperson Kiran Mazumdar-Shaw said. WebSep 16, 2024 · Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, said on Thursday that it will offer about 15% stake to Serum Institute Life Sciences Pvt Ltd (SILS), a subsidiary of Serum Institute of India, at a post-money valuation of $4.9 billion. In return, BBL will get committed access to 100 million doses of vaccines annually for 15 years and … WebAs part of the deal announced by Biocon Biologics and Serum Institute Life Sciences last year, the former will offer about 15% stake to the latter at a post-money valuation of $4.9 billion, for which it will get committed access to 100 million doses of vaccines a year for 15 years. This would be mainly from Serum Institute’s upcoming vaccine ... most comfortable sneakers ever